RE: Comment on Asghari et al. 2017: On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity
- PMID: 29255933
- DOI: 10.1007/s00204-017-2136-1
RE: Comment on Asghari et al. 2017: On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity
Comment in
-
Reply to Zamani and Hassanian-Moghaddam, 2017: being specific and targeting disease-causing pathology matter in therapeutics.Arch Toxicol. 2018 May;92(5):1907-1908. doi: 10.1007/s00204-018-2154-7. Epub 2018 Jan 13. Arch Toxicol. 2018. PMID: 29332132 No abstract available.
Comment on
-
On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity.Arch Toxicol. 2017 Sep;91(9):3109-3120. doi: 10.1007/s00204-017-1998-6. Epub 2017 May 27. Arch Toxicol. 2017. PMID: 28551710
-
In response to the comments on our recently published paper entitled "on the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity".Arch Toxicol. 2017 Oct;91(10):3457-3458. doi: 10.1007/s00204-017-2029-3. Epub 2017 Jul 21. Arch Toxicol. 2017. PMID: 28733888 No abstract available.
-
Comment on Asghari et al. 2017: On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity. Arch Toxicol [Epub ahead of print]. doi:10.1007/s00204-017-1998-6.Arch Toxicol. 2017 Oct;91(10):3455-3456. doi: 10.1007/s00204-017-2028-4. Epub 2017 Jul 21. Arch Toxicol. 2017. PMID: 28733889 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources